AI Spotlight on MLAB
Company Description
Mesa Laboratories, Inc.develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally.The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries.
This segment also provides testing and laboratory services primarily to the dental industry.Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions.This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research.
The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments.This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems.Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology.
The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Market Data
Last Price | 137.69 |
Change Percentage | -3.21% |
Open | 141.35 |
Previous Close | 142.25 |
Market Cap ( Millions) | 748 |
Volume | 33300 |
Year High | 149.5 |
Year Low | 83.68 |
M A 50 | 129.4 |
M A 200 | 118.05 |
Financial Ratios
FCF Yield | 4.78% |
Dividend Yield | 0.46% |
ROE | -114.19% |
Debt / Equity | 138.03% |
Net Debt / EBIDTA | -86.47% |
Price To Book | 4.62 |
Price Earnings Ratio | -3.03 |
Price To FCF | 20.9 |
Price To sales | 3.27 |
EV / EBITDA | -4.12 |
News
- Jan -17 - Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025
- Jan -06 - MESA LABS DECLARES QUARTERLY DIVIDEND
- Nov -07 - Mesa Labs (MLAB) Lags Q2 Earnings and Revenue Estimates
- Nov -07 - Mesa Labs Announces Second Quarter Results
- Oct -02 - MESA LABS DECLARES QUARTERLY DIVIDEND
- Aug -26 - Mesa Labs (MLAB) Moves to Strong Buy: Rationale Behind the Upgrade
- Aug -26 - New Strong Buy Stocks for August 26th
- Aug -05 - Mesa Labs Announces First Quarter Results
- Jul -08 - MESA LABS DECLARES QUARTERLY DIVIDEND
- Jun -05 - Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results
- May -31 - Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results
- May -22 - Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
- Apr -08 - MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES
- Apr -08 - Best Value Stocks to Buy for April 8th
- Apr -04 - MESA LABS DECLARES QUARTERLY DIVIDEND
- Apr -01 - Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024
- Mar -15 - Mesa Labs Releases Second Annual Responsible Business Program Brochure
- Feb -05 - Mesa Labs (MLAB) Lags Q3 Earnings and Revenue Estimates
- Feb -05 - Why Investors Need to Take Advantage of These 2 Retail and Wholesale Stocks Now
- Feb -05 - Mesa Labs Announces Third Quarter Results
Business Breakdown
Expected Mid-Term Growth
Segment nΒ°1 -> Sterilization and Disinfection Control
Expected Growth : 7.8 %
What the company do ?
Sterilization and Disinfection Control from Mesa Laboratories, Inc. ensures effective sterilization and disinfection of medical devices and surfaces, preventing infection and contamination.
Why we expect these perspectives ?
Growing demand for sterilization and disinfection control solutions, driven by increasing concerns over hospital-acquired infections and the need for effective infection prevention and control measures, will drive market growth.
Segment nΒ°2 -> Clinical Genomics
Expected Growth : 10.5 %
What the company do ?
Clinical Genomics from Mesa Laboratories, Inc. provides molecular diagnostic testing for infectious diseases, genetic disorders, and cancer, enabling accurate diagnosis and personalized treatment.
Why we expect these perspectives ?
Increasing demand for personalized medicine, advancements in molecular diagnostics, and growing incidence of infectious diseases and cancer drive the growth of Clinical Genomics market.
Segment nΒ°3 -> Biopharmaceutical Development
Expected Growth : 8.1 %
What the company do ?
Mesa Laboratories' Biopharmaceutical Development provides testing and analytical services for biologics, vaccines, and gene therapies, ensuring product quality and safety.
Why we expect these perspectives ?
Increasing demand for biologics, vaccines, and gene therapies drives growth in testing and analytical services. Rising regulatory requirements for product quality and safety, coupled with advancements in biotechnology, fuel the need for Mesa Laboratories' services.
Segment nΒ°4 -> Calibration Solutions
Expected Growth : 7.8 %
What the company do ?
Mesa Laboratories' Calibration Solutions provide accurate and reliable calibration services for a wide range of instruments and equipment, ensuring precise measurements and compliance with regulatory standards.
Why we expect these perspectives ?
Growing demand for precise measurements and compliance with regulatory standards drives the calibration solutions market. Increasing adoption in pharmaceutical, biotechnology, and medical device industries, coupled with advancements in instrumentation and technology, fuels growth.
Mesa Laboratories, Inc. Products
Product Range | What is it ? |
---|---|
DataLoggers | Mesa's data loggers are designed to monitor and record temperature, humidity, and other environmental parameters in various industries such as pharmaceutical, medical, and food processing. |
Cold Chain Monitoring Solutions | Mesa's cold chain monitoring solutions provide real-time monitoring and tracking of temperature-sensitive products during transportation and storage. |
Environmental Monitoring Systems | Mesa's environmental monitoring systems provide real-time monitoring and alerting of temperature, humidity, and other environmental parameters in critical infrastructure such as data centers and laboratories. |
Calibration and Validation Services | Mesa's calibration and validation services provide accurate and reliable calibration of temperature and humidity sensors, as well as validation of environmental monitoring systems. |
Continuous Monitoring Systems | Mesa's continuous monitoring systems provide real-time monitoring and alerting of temperature, humidity, and other environmental parameters in critical infrastructure such as hospitals and laboratories. |
Mesa Laboratories, Inc.'s Porter Forces
Threat Of Substitutes
Mesa Laboratories, Inc. operates in a niche market, and the threat of substitutes is moderate. While there are some alternative products available, they are not as effective or efficient as Mesa's products.
Bargaining Power Of Customers
Mesa Laboratories, Inc. has a diverse customer base, and no single customer has significant bargaining power. The company's products are also critical to its customers' operations, reducing their bargaining power.
Bargaining Power Of Suppliers
Mesa Laboratories, Inc. relies on a few key suppliers for critical components. While the company has some bargaining power, the suppliers also have some leverage due to the specialized nature of the components.
Threat Of New Entrants
The medical device industry has high barriers to entry, including regulatory hurdles and significant capital requirements. This limits the threat of new entrants and gives Mesa Laboratories, Inc. a competitive advantage.
Intensity Of Rivalry
The medical device industry is highly competitive, with several established players competing for market share. Mesa Laboratories, Inc. must continually innovate and improve its products to maintain its market position.
Capital Structure
Value | |
---|---|
Debt Weight | 30.56% |
Debt Cost | 3.95% |
Equity Weight | 69.44% |
Equity Cost | 8.03% |
WACC | 6.79% |
Leverage | 44.00% |
Mesa Laboratories, Inc. : Quality Control
Mesa Laboratories, Inc. passed 3 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
Company | Rational |
---|---|
CPSH | CPS Technologies Corporation produces and sells advanced material solutions to the transportation, automotive, energy, computing/internet, telecommunication, aerospace, defense, and oil and gas markets. It primarily offers metal matrix composites that β¦ |
DAIO | Data I/O Corporation engages in the design, manufacture, and sale of programming and security deployment systems and services for electronic device manufacturers in the United States, Europe, and internationally. The β¦ |
LPTH | LightPath Technologies, Inc. designs, develops, manufactures, and distributes optical components and assemblies. The company offers precision molded glass aspheric optics, molded and diamond-turned infrared aspheric lenses, and other optical components β¦ |
BKSY | BlackSky Technology Inc. provides geospatial intelligence, imagery and related data analytic products and services, and mission systems that include the development, integration, and operations of satellite and ground systems to β¦ |
WRAP | Wrap Technologies, Inc., a public safety technology and services company, develops policing solutions to law enforcement and security personnel. The company develops BolaWrap 150, a hand-held remote restraint device that β¦ |